Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Synthesis and biological evaluation of novel aliphatic amido-quaternary ammonium salts for anticancer chemotherapy: Part I

Full metadata record
DC Field Value Language
dc.contributor.authorYang, Jee Sun-
dc.contributor.authorSong, Doona-
dc.contributor.authorLee, Boah-
dc.contributor.authorKo, Won Jin-
dc.contributor.authorPark, Song-Kyu-
dc.contributor.authorWon, Misun-
dc.contributor.authorLee, Kiho-
dc.contributor.authorKim, Hwan Mook-
dc.contributor.authorHan, Gyoonhee-
dc.date.accessioned2021-09-07T11:03:25Z-
dc.date.available2021-09-07T11:03:25Z-
dc.date.created2021-06-14-
dc.date.issued2011-07-
dc.identifier.issn0223-5234-
dc.identifier.urihttps://scholar.korea.ac.kr/handle/2021.sw.korea/112101-
dc.description.abstractWe synthesized novel aliphatic amido-quaternary ammonium salts in an effort to discover anticancer agents that increase Ras homolog gene family, member B, (RhoB) levels. These compounds exert anti-proliferative activities against several human cancer cell types. Seventeen compounds, varying in aliphatic carbon chain length and N-substituents, were synthesized and their biological activities were evaluated. Of these 17 compounds, compound 31 emerged as the most promising anticancer compound by promoting apoptosis through the RhoB mediated pathway. Potent biological activities observed for these novel aliphatic amido-quaternary ammonium salt analogues support their potential as anticancer, chemotherapeutic agents. (C) 2011 Elsevier Masson SAS. All rights reserved.-
dc.languageEnglish-
dc.language.isoen-
dc.publisherELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER-
dc.subjectDEPENDENT KINASE MODULATORS-
dc.subjectRAS ONCOGENES-
dc.subjectRHO-PROTEINS-
dc.subjectHUMAN CANCER-
dc.subjectPATHWAY-
dc.subjectMETASTASIS-
dc.subjectPERIFOSINE-
dc.subjectINVASION-
dc.subjectFAMILY-
dc.subjectTUMOR-
dc.titleSynthesis and biological evaluation of novel aliphatic amido-quaternary ammonium salts for anticancer chemotherapy: Part I-
dc.typeArticle-
dc.contributor.affiliatedAuthorPark, Song-Kyu-
dc.identifier.doi10.1016/j.ejmech.2011.04.009-
dc.identifier.scopusid2-s2.0-79957474685-
dc.identifier.wosid000291895200023-
dc.identifier.bibliographicCitationEUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, v.46, no.7, pp.2861 - 2866-
dc.relation.isPartOfEUROPEAN JOURNAL OF MEDICINAL CHEMISTRY-
dc.citation.titleEUROPEAN JOURNAL OF MEDICINAL CHEMISTRY-
dc.citation.volume46-
dc.citation.number7-
dc.citation.startPage2861-
dc.citation.endPage2866-
dc.type.rimsART-
dc.type.docTypeArticle-
dc.description.journalClass1-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalResearchAreaPharmacology & Pharmacy-
dc.relation.journalWebOfScienceCategoryChemistry, Medicinal-
dc.subject.keywordPlusDEPENDENT KINASE MODULATORS-
dc.subject.keywordPlusRAS ONCOGENES-
dc.subject.keywordPlusRHO-PROTEINS-
dc.subject.keywordPlusHUMAN CANCER-
dc.subject.keywordPlusPATHWAY-
dc.subject.keywordPlusMETASTASIS-
dc.subject.keywordPlusPERIFOSINE-
dc.subject.keywordPlusINVASION-
dc.subject.keywordPlusFAMILY-
dc.subject.keywordPlusTUMOR-
dc.subject.keywordAuthorAliphatic amido-quaternary ammonium salts-
dc.subject.keywordAuthorRhoB-
dc.subject.keywordAuthorGTPase RAt Sarcoma (Ras)-
dc.subject.keywordAuthorPerifosine-
dc.subject.keywordAuthorPiperazine alkyl derivatives-
dc.subject.keywordAuthorNSC126188-
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Pharmacy > Department of Pharmaceutical Science > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher PARK, SONG KYU photo

PARK, SONG KYU
College of Pharmacy (Department of Pharmaceutical Science)
Read more

Altmetrics

Total Views & Downloads

BROWSE